Literature DB >> 21086903

Perceptions and beliefs in sarcoidosis.

J Ireland1, M Wilsher.   

Abstract

BACKGROUND: Sarcoidosis is a chronic multisystem disease with a high prevalence of depression although this is often not recognised. It is not known how patients perceive their disease or the medications required for treatment. We hypothesised that perceptions of illness and beliefs about medications may relate to psychological distress in this condition.
METHODS: 81(42 female) patients with sarcoidosis completed the following: Hospital Anxiety and Depression Scale, Illness Perception Questionnaire, Beliefs about Medications Questionnaire. Demographic and clinical data were collected and the physician's perception of symptom severity and relationship to sarcoidosis recorded.
RESULTS: The prevalence of depression (23%) and anxiety (33%) was high and related to self reported symptoms of sarcoidosis. Those on current treatment reported different illness perceptions than those not, and illness perceptions related to anxiety and depression scores. The majority of the sample felt that sarcoid medications were unnecessary but few patients reported concerns about potential adverse consequences of taking them. Beliefs about medications were related to illness perceptions but not associated with anxiety or depression scores or with clinical perception of disease state. There were significant gender differences in perceptions of illness and beliefs about medications.
CONCLUSIONS: These data confirm earlier reports that anxiety and depression are common in patients with sarcoidosis and in turn perceptions of illness impact on emotional wellness in this disorder. Use of the Illness Perceptions Questionnaire in clinical practice may help to identify those patients who would benefit from interventions to change their perceptions of illness.

Entities:  

Mesh:

Year:  2010        PMID: 21086903

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  9 in total

Review 1.  Disease Burden and Variability in Sarcoidosis.

Authors:  Alicia K Gerke; Marc A Judson; Yvette C Cozier; Daniel A Culver; Laura L Koth
Journal:  Ann Am Thorac Soc       Date:  2017-12

Review 2.  Patient reported outcome measures (PROMs) in sarcoidosis.

Authors:  Rikke Flor Thunold; Anders Løkke; Adam Langballe Cohen; Hilberg Ole; Elisabeth Bendstrup
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Sarcoidosis: an orphan disease needs to be adopted.

Authors:  Rashi Jain; Anant Mohan; Rinkee Kumari; Randeep Guleria
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

4.  Sarcoidosis: psychotherapy and long-term outcome-a case report.

Authors:  Giancarlo Trombini; Elena Trombini
Journal:  Case Rep Med       Date:  2012-04-03

5.  Cognitive-behavioural theories and adherence: Application and relevance in antiretroviral therapy.

Authors:  Adegoke O Adefolalu
Journal:  South Afr J HIV Med       Date:  2018-04-12       Impact factor: 2.744

Review 6.  Comprehensive Care for Patients with Sarcoidosis.

Authors:  Catharina C Moor; Vivienne Kahlmann; Daniel A Culver; Marlies S Wijsenbeek
Journal:  J Clin Med       Date:  2020-02-01       Impact factor: 4.241

Review 7.  Sarcoidosis: rarely a single system disorder.

Authors:  Katrin Mannes; Paul S Thomas
Journal:  Breathe (Sheff)       Date:  2020-12

8.  Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners.

Authors:  C C Moor; M J G van Manen; P M van Hagen; J R Miedema; L M van den Toorn; Y Gür-Demirel; A P C Berendse; J A M van Laar; M S Wijsenbeek
Journal:  Lung       Date:  2018-08-07       Impact factor: 2.584

9.  Psychological burden associated with worse clinical outcomes in sarcoidosis.

Authors:  Michelle Sharp; Taylor Brown; Edward Chen; Cynthia S Rand; David R Moller; Michelle N Eakin
Journal:  BMJ Open Respir Res       Date:  2019-09-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.